Add like
Add dislike
Add to saved papers

Intracorporeal robot-assisted microsurgical vasovasostomy for the treatment of bilateral vasal obstruction occurring following bilateral inguinal hernia repairs with mesh placement.

PURPOSE: Various surgical approaches have been described to manage iatrogenic inguinal vasal obstruction, including open microscopic, laparoscopic and robot-assisted techniques. The open and laparoscopic approaches are often limited in cases of extensive inguinal obstruction or inadequate intra-abdominal vasal length. The robotic approach offers novel opportunities to the operating surgeon, including performing microsurgical anastomoses in traditionally challenging locations. To our knowledge we describe the first intracorporeal robot-assisted, microsurgical vasovasostomy for iatrogenic vasal obstruction not amenable to standard microscopic repair.

MATERIALS AND METHODS: Bilateral intracorporeal robot-assisted microsurgical vasovasostomy was performed. The proximal vasa were transected and obstruction of the distal segments was confirmed. After docking the robot the intracorporeal regions of the vasa were transected at the internal ring. The proximal vasal segments were passed intracorporeally and approximated with 5-zero polypropylene sutures. A standard 2-layer anastomosis was performed intracorporeally using 10-zero/9-zero sutures.

RESULTS: Total operative time was 278 minutes. No intraoperative or postoperative complications were noted. Semen analysis 8 weeks after the procedure demonstrated a total volume of 5.4 cc, 8.4 × 10(6) sperm per ml, 45.4 × 10(6) total sperm and 16% motility, consistent with a successful result.

CONCLUSIONS: To our knowledge this represents the first reported case of intracorporeal outpatient vasovasostomy. These results demonstrate the feasibility of the procedure and highlight unique aspects of the robotic approach, which may offer advantages over the traditional microscope in select cases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app